Westwood Holdings Group’s Crinetics Pharmaceuticals CRNX Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2023 Q2	–	Sell	-28,402	Closed	-$456K	–	495
2023 Q1	$456K	Buy	28,402 +3,031	+12%	+$48.7K	﹤0.01%	410
2022 Q4	$464K	Buy	25,371 +4,329	+21%	+$79.2K	﹤0.01%	417
2022 Q3	$413K	Buy	+21,042	New	+$413K	﹤0.01%	390